It should be noted that, in our previous study, using a mixture of the two individual APP and Tau peptides, we demonstrated a similar protective effect on cognition not only when administrating the Mix at three months of age, before cognitive deficiency is observed, but also at the age of six months, when cognitive impairments were already evident. This evidence concerns the gene MAPT and Cognitive impairment.